Franklin M. Berger, Director at Atea Pharmaceuticals, Inc. (AVIR), bought 25,000 shares at $3.19 ($81K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Open-market purchase of $81k AVIR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 15,000 | $48K | 58.7% |
| 2 | $3.36 | 10,000 | $34K | 41.3% |
| Total | $3.26 avg | 25,000 | $81K | 100% |
| Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |
| RAIN | BUY | 2022-11-23 | $988K | — | Filing → |